JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 May 2008

J Clin Pathol. Published Online First: 1 October 2007. doi:10.1136/jcp.2007.050666
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jcp.2007.050666v1
61/5/658    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chai, C.-Y.
Right arrow Articles by Yang, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chai, C.-Y.
Right arrow Articles by Yang, C.-H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Bladder Cancer

Histopathology

Hypoxia-inducible factor-1{alpha} Expression Correlates with Focal Macrophage Infiltration, Angiogenesis and Unfavorable Prognosis in Urothelial Carcinoma

Chee-Yin Chai 1*, Wan-Tzu Chen 2, Wen-Chun Hung 3, Wan-Yi Kang 2, Ya-Chun Huang 1, Yue-Chiu Su 2 and Ching-Hsiu Yang 2

1 Department of Pathology, College of Medicine, Kaohsiung Medical University, Taiwan
2 Department of Pathology, Kaohsiung Medical University Chung-Ho Memorial Hospital, Taiwan
3 Institute of Biomedical Sciences, National Sun Yat-Sen University, Taiwan

* To whom correspondence should be addressed. E-mail: cychai{at}kmu.edu.tw.

Accepted 6 September 2007


*   Abstract

Background: Hypoxia inducible factor-1 alpha (HIF-1{alpha}) is a critical regulatory protein of cellular response to hypoxia and is closely related to angiogenic process. Aims: To explore the potential role and the prognostic value of HIF-1{alpha} in urothelial carcinoma (UC). Methods: Clinicopathological and follow up data on 99 UC cases were reviewed and immunostained for HIF-1{alpha}, CD68, VEGF and CD31 antigen. Tumor-associated macrophage (TAM) counts and HIF-1{alpha} expression were compared with clinicopathologic characteristics, overall survival (OS) and disease-free survival rates (DFS). Results: High expression of HIF-1{alpha} was detected in 55 of 99 (55.6%) tumors. HIF-1{alpha} expression was correlated with tumor size, histological grade, tumor invasiveness and recurrence. VEGF and microvessel density (MVD) demonstrated their positive correlation with HIF-1{alpha} overexpression, supporting the correlation of HIF-1{alpha} upregulation with tumor angiogenesis. Higher TAM infiltration was identified in high expression of HIF-1{alpha} cases rather than HIF-1{alpha} low expression cases (P=0.002). Kaplan-Meier analysis found that HIF-1{alpha} overexpression and high TAM count was only associated with worse DFS (P=0.009, P=0.023) but was not associated with OS (P=0.696, P=0.141). Multivariate analyses indicated only tumor size (P=0.038) to be an independently significant prognostic factors for OS, in addition, HIF-1{alpha} expression (P=0.011), as well as histological grade (P=0.038), and MVD (P=0.004), to be independently significant prognostic factors for DFS. Conclusions: Our results indicated that HIF-1{alpha} is a key regulator of the angiogenic cascade. We showed that HIF-1{alpha} is an independent prognostic factor for disease-free survival.

Key Words: angiogenesis, hypoxia inducible factor-1 alpha, microvessel density, tumor associated-macrophage, urothelial carcinoma







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.